proximal gastric cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Patients with advanced proximal gastric cancer treated in our department since 2015, including Siewert type II and III adenocarcinoma of the esophagogastric junction, gastric fundus cancer, and upper gastric body cancer; (2) Postoperative pathological diagnosis confirmed adenocarcinoma; (3) Complete clinical data available; (4) Surgical procedures included total gastrectomy or proximal gastrectomy.
Exclusion criteria
Exclusion criteria: (1) Patients with concurrent malignancies in other sites; (2) Incomplete clinical data; (3) Presence of severe cardiopulmonary dysfunction, hepatic or renal insufficiency, or other contraindications to surgery; (4) Loss to follow-up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1-year overall survival;3 years overall survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| Operation time;Intraoperative blood loss (mL);Number of lymph nodes dissected and metastasis;hospital stay (days);Resection margin status (R0, R1, R2);Postoperative complications rate;Follow-up completeness rate;Postoperative quality of life ;loss-to-follow-up rate;Follow-up duration (months); | — |
Countries
China
Contacts
Tianjin People’s Hospital